SCM
LXRX icon

Sio Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Sio Capital Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-21,600
Closed -$120K – 77
2019
Q1 		$120K Hold
21,600
– – 0.03% 69
2018
Q4 		$143K Hold
21,600
– – 0.05% 67
2018
Q3 		$230K Buy
+21,600
New +$248K 0.08% 60

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Sio Capital Management's LXRX Position: Q4 2019 in Review

Sio Capital Management sold out of Lexicon Pharmaceuticals (LXRX) in Q4 2019, closing a stake of 20,667 shares — an estimated $62K sold.

Sio Capital Management first reported a position in LXRX in Q3 2019 and held it in 1 quarter. The position peaked at $62K in Q3 2019. 115 funds tracked by Wall St. Rank hold LXRX as of Q4 2019.

  • Sio Capital Management reported no remaining Lexicon Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Sio Capital Management sold 20,667 Lexicon Pharmaceuticals shares in Q4 2019, an estimated $62K.
  • Sio Capital Management first reported a position in Lexicon Pharmaceuticals in Q3 2019 and held it in 1 quarter.
  • Sio Capital Management's Lexicon Pharmaceuticals position peaked at $62K in Q3 2019.
  • 115 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2019.

Based on Sio Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.